This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use

Evgen Pharma plc Clinical Trial Approval for Phase II Study in Breast Cancer 23 August 2016

Evgen Pharma plc, a clinical stage drug development company focused on the treatment of cancer and neurological conditions, has today announced that it has received a Clinical Trial Approval (CTA) from the UK’s regulatory agency for the commencement of its Phase II clinical trial of SFX-01 in breast cancer.

> Read More

Soft Skills For Scientists Workshops this Autumn 19 August 2016

Soft Skills for Scientists: do you need to improve communication and productivity in your business? Workshops for professionals in science and technology this autumn. Discounts for Bionow members!

> Read More

Orla alpha-laminin-2 peptides used for promoting differentiation of cultured myoblasts 18 August 2016

Orla surfaces have been used to promote myoblast cell differentiation in a study led by Prof Michelle Peckham of University of Leeds. Orla’s surfaces outperformed traditionally used gelatin coated glass coverslips in fusion and differentiation assays with three muscle cell lines.

> Read More